SLCO1B1 and Hyperbilirubinemia: No adverse events such as elevated MTX concentration, ALT elevation, hyperbilirubinemia, or prognosis were statistically correlated to two polymorphisms in SLCO1B1 (rs11045879 and rs4149056) (Tables 2 and 3).